United Therapeutics Corporation Equity Securities, FV-NI, Realized Gain
United Therapeutics Corporation (UTHR) reported Equity Securities, FV-NI, Realized Gain of $900.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGain · last filed 2025-02-26
- United Therapeutics Corporation equity securities, fv-ni, realized gain for fiscal 2022 was $900.00K, a 99.03% decline from fiscal 2021.
- United Therapeutics Corporation equity securities, fv-ni, realized gain for fiscal 2021 was $92.60M, a 2623.53% increase from fiscal 2020.
- United Therapeutics Corporation equity securities, fv-ni, realized gain for fiscal 2020 was $3.40M, a 30.77% increase from fiscal 2019.
- United Therapeutics Corporation equity securities, fv-ni, realized gain for fiscal 2019 was $2.60M.
| Period end | Equity Securities, FV-NI, Realized Gain 12 month |
|---|---|
| 2022-12-31 | $900.00K 10-K · filed 2025-02-26 |
| 2021-12-31 | $92.60M 10-K · filed 2024-02-21 |
| 2020-12-31 | $3.40M 10-K · filed 2023-02-22 |
| 2019-12-31 | $2.60M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |